A priority system of assessment in a client recently started on ...

[ereecah]

A priority system of assessment in a client recently started on efavirenz (Sustiva) includes:
 
  1. pulmonary.
  2. CNS.
  3. GI.
  4. cardiac.

Question 2

The nurse is caring for a client with cancer. The family asks the nurse to explain the differences between benign and malignant tumors. The nurse states that the main difference is:
 
  1. Benign tumors are fast growing, remain localized, and can kill the host.
  2. Malignant tumors are slow growing but invasive, and they can kill the host.
  3. Benign tumors are slow growing but invasive.
  4. Malignant tumors are rapidly growing and invasive, and they can kill the host.

[Eazy416]

Answer to Question 1

Correct Answer: 2
Rationale 1: Although important, the pulmonary system is not the priority system for assessment with efavirenz.
Rationale 2: CNSadverse effects are observed in at least 50 of the clients when first starting therapy with efavirenz.
Rationale 3: Although important, the GI system is not the priority system for assessment with efavirenz.
Rationale 4: Although important, the cardiac system is not the priority system for assessment with efavirenz.
Global Rationale: Although assessment of all systems is important, adverse effects are most commonly found in the CNS system.

Answer to Question 2

Correct Answer: 4
Rationale 1: Benign tumors are slow growing, remain localized, and rarely cause death.
Rationale 2: Malignant tumors are not slow growing, but they are invasive and can kill the host.
Rationale 3: Benign tumors are slow growing but remain localized.
Rationale 4: Malignant tumors grow rapidly, are invasive, and can kill the host.
Global Rationale: Whereas benign tumors are usually slow growing, remain localized, and rarely cause death, malignant tumors are rapidly growing, invasive, and will kill the host if left untreated.

[ereecah]

TYSM

[sultansheikh]

Thanks for the timely response, appreciate it